UniDoc Health Corp (TSE:UDOC)
:UDOC
Top Page
UniDoc Health Corp
(UDOC)
Select Model
Select Model
Rating:42Neutral
Price Target:
C$0.11
▼(-21.43% Downside)
Action:ReiteratedDate:03/26/26
The score is primarily held down by weak financial performance—large operating losses, significant cash burn, and negative equity—despite strong recent revenue growth. Technicals also weigh on the score with the stock trading below all major moving averages and negative MACD. Valuation is difficult to support with a negative P/E and no dividend yield provided.
Positive Factors
Revenue Growth
Sustained TTM revenue growth of roughly 52% indicates that UniDoc's commercial traction is expanding. Over a 2-6 month horizon this trend supports scaling of platform usage, validates demand for H3 deployments, and provides a foundation to leverage fixed-cost absorption as volumes grow.
Negative Factors
Cash Burn
Consistent negative operating and free cash flow indicate the business is converting losses into real cash outflows, pressuring liquidity. Over the next several months this persistent burn elevates refinancing or dilution risk if revenue ramp does not accelerate or expenses are not curtailed.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Sustained TTM revenue growth of roughly 52% indicates that UniDoc's commercial traction is expanding. Over a 2-6 month horizon this trend supports scaling of platform usage, validates demand for H3 deployments, and provides a foundation to leverage fixed-cost absorption as volumes grow.
Read all positive factors
UniDoc Health Corp (UDOC) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$9.93M
Dividend YieldN/A
Average Volume (3M)67.00K
Price to Earnings (P/E)―
Beta (1Y)0.20
Revenue GrowthN/A
EPS Growth48.94%
CountryCA
EmployeesN/A
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding86,350,090
10 Day Avg. Volume18,137
30 Day Avg. Volume67,001
Financial Highlights & Ratios
PEG Ratio-0.02
Price to Book (P/B)28.14
Price to Sales (P/S)0.00
P/FCF Ratio-2.44
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
UniDoc Health Corp Business Overview & Revenue Model
Company Description
UniDoc Health Corp. operates as a virtual health/telemedicine solutions company in Canada. It offers Virtual Health Clinics, a customizable solution that offers safe and secure ways to connect patients in urban, rural, and remote locations with me...
How the Company Makes Money
UniDoc’s revenue model is based on monetizing the deployment and use of its telehealth infrastructure, primarily the H3 Health Cube solution. Key potential revenue streams include: (1) sales of H3 Health Cubes and related equipment to customers (e...
UniDoc Health Corp Financial Statement Overview
Summary
Income Statement
12
Very Negative
Balance Sheet
28
Negative
Cash Flow
14
Very Negative
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 697.06K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 123.10K | -37.57K | -68.26K | -64.22K | 0.00 |
| EBITDA | -2.87M | -5.93M | -2.18M | -1.28M | -237.32K |
| Net Income | -3.12M | -6.06M | -2.26M | -1.36M | -237.32K |
Balance Sheet | |||||
| Total Assets | 2.30M | 2.91M | 517.08K | 320.47K | 288.40K |
| Cash, Cash Equivalents and Short-Term Investments | 637.80K | 1.25M | 398.88K | 51.32K | 281.84K |
| Total Debt | 37.18K | 68.68K | 74.86K | 94.79K | 200.00K |
| Total Liabilities | 2.33M | 2.24M | 2.38M | 1.22M | 425.13K |
| Stockholders Equity | -27.84K | 664.52K | -1.86M | -900.79K | -136.73K |
Cash Flow | |||||
| Free Cash Flow | -3.31M | -7.66M | -559.92K | -818.36K | 17.25K |
| Operating Cash Flow | -2.98M | -7.40M | -559.92K | -755.59K | 17.25K |
| Investing Cash Flow | -325.82K | -257.76K | 0.00 | -62.77K | 0.00 |
| Financing Cash Flow | 1.48M | 8.51M | 907.48K | 15.25K | 264.59K |
UniDoc Health Corp Technical Analysis
Negative
0.14
Price Trends
0.13
Negative
0.15
Negative
0.18
Negative
Market Momentum
>-0.01
Negative
48.10
Neutral
83.80
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:UDOC, the sentiment is Negative. The current price of 0.14 is above the 20-day moving average (MA) of 0.12, above the 50-day MA of 0.13, and below the 200-day MA of 0.18, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 48.10 is Neutral, neither overbought nor oversold. The STOCH value of 83.80 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:UDOC.
UniDoc Health Corp Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
68 Neutral | C$436.30M | 90.72 | 2.75% | ― | 59.34% | -23.48% | |
53 Neutral | C$12.38M | -11.57 | ― | ― | 16.04% | -455.38% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
48 Neutral | C$50.98M | -2.31 | -207.53% | ― | ― | 7.04% | |
42 Neutral | C$9.93M | -5.12 | 6239.15% | ― | ― | 48.94% | |
42 Neutral | C$6.60M | -4.68 | ― | ― | ― | 81.01% |
* Healthcare Sector Average
TSE:UDOC
UniDoc Health Corp
0.12
-0.21
-64.62%
TSE:VHI
Vitalhub
6.90
-3.11
-31.07%
TSE:AIDR
Rocket Doctor AI
0.60
0.13
27.66%
TSE:CHS
Comprehensive Healthcare Systems Inc
0.69
0.29
72.50%
TSE:NARA
PanGenomic Health, Inc. Class A
0.47
0.23
95.83%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.